84694 20230914083235.0 doi 10.1177/2049936119868028 sideral 112983 ART-2019-112983 eng Roc, L. Rapid subacute myelopathy following kidney transplantation from HTLV-1 donors: role of immunosuppresors and failure of antiretrovirals 2019 Access copy available to the general public Unrestricted Two kidney transplant recipients from a single donor became infected with HTLV-1 (human T-lymphotropic virus type 1) in Spain. One developed myelopathy 8 months following surgery despite early prescription of antiretroviral therapy. The allograft was removed from the second recipient at month 8 due to rejection and immunosuppressors discontinued. To date, 3 years later, this patient remains infected but asymptomatic. HTLV-1 infection was recognized retrospectively in the donor, a native Spaniard who had sex partners from endemic regions. Our findings call for a reappraisal of screening policies on donor-recipient organ transplantation. Based on the high risk of disease development and the large flux of persons from HTLV-1 endemic regions, pre-transplant HTLV-1 testing should be mandatory in Spain. info:eu-repo/semantics/openAccess by-nc http://creativecommons.org/licenses/by-nc/3.0/es/ info:eu-repo/semantics/article info:eu-repo/semantics/publishedVersion de Mendoza, C. Fernandez-Alonso, M. Reina, G. Soriano, V. Rodriguez, C. Vera, M. del Romero, J. Marcaida, G. Ocete, M.D. Caballero, E. Molina, I. Aguilera, A. Rodriguez-Calvino, J.J. Navarro, D. Rivero, C. Vilarino, M.D. Benito, R. Universidad de Zaragoza (orcid)0000-0001-5134-1006 Algarate, S. Gil, J. de Lejarazu, R.O. Rojo, S. Eiros, J.M. San Miguel, A. Manzardo, C. Miro, J.M. Garcia, J. Paz, I. Poveda, E. Calderon, E. Escudero, D. Trigo, M. Diz, J. Garcia-Campello, M. Rodriguez-Iglesias, M. Hernandez-Betancor, A. Martin, A.M. Ramos, J.M. Gimeno, A. Gutierrez, F. Rodriguez, J.C. Sanchez, V. Gomez-Hernando, C. Cilla, G. Perez-Trallero, E. Lopez-Aldeguer, J. Fernandez-Pereira, L. Niubo, J. Hernandez, M. Lopez-Lirola, A.M. Gomez-Sirvent, J.L. Force, L. Cifuentes, C. Perez, S. Morano, L. Raya, C. Gonzalez-Praetorius, A. Perez, J.L. Penaranda, M. Hernaez-Crespo, S. Montejo, J.M. Martinez-Sapina, A. Viciana, I. Cabezas, T. Lozano, A. Fernandez, J.M. Garcia-Bermejo, I. Gaspar, G. Garcia, R. Gorgolas, M. Vegas, C. Blas, J. Miralles, P. Valeiro, M. Aldamiz, T. Margall, N. Guardia, C. do Pico, E. Polo, I. Aguinaga, A. Ezpeleta, C. Sauleda, S. Piron, M. Gonzalez, R. Barea, L. Jimenez, A. Blanco, L. Suarez, A. Rodriguez-Avial, I. Perez-Rivilla, A. Parra, P. Fernandez, M. Trevino, A. Requena, S. Benitez-Gutierrez, L. Cuervas-Mons, V. Barreiro, P. Corral, O. Gomez-Gallego, F. 1008 630 Universidad de Zaragoza Dpto. Microb.Med.Pr.,Sal.Públ. Área Microbiología 6 (2019), 1-8 Therapeutic Advances in Infectious Disease 2049-9361 606625 http://zaguan.unizar.es/record/84694/files/texto_completo.pdf Versión publicada 114935 http://zaguan.unizar.es/record/84694/files/texto_completo.jpg?subformat=icon icon Versión publicada oai:zaguan.unizar.es:84694 articulos driver 2023-09-13-10:45:28 ARTICLE